Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares shot up 8.4% during trading on Friday . The company traded as high as GBX 1.68 ($0.02) and last traded at GBX 1.68 ($0.02). 925,345 shares were traded during trading, a decline of 33% from the average session volume of 1,371,682 shares. The stock had previously closed at GBX 1.55 ($0.02).
Cizzle Biotechnology Trading Up 8.1 %
The stock has a market cap of £6.64 million, a PE ratio of -152.00 and a beta of 0.42. The firm has a fifty day simple moving average of GBX 1.81 and a two-hundred day simple moving average of GBX 1.84.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- Health Care Stocks Explained: Why You Might Want to Invest
- Who Will Come Out on Top in the Chinese Coffee Wars?
- Consumer Staples Stocks, Explained
- Zscaler: A Heavily Downgraded Stock With Big Upside Potential
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
